Context Therapeutics CNTX
NASDAQ CNTX
$0.23 -0.01 (-4.21%)
As of: Oct 21, 2026 · 11:02 AM EDT

Context Therapeutics (CNTX) Total Debt (2020)

Updated

Context Therapeutics (CNTX) recorded Total Debt of $5.95 million in Q4 2020.

Analysis

Context Therapeutics (CNTX) Total Debt (2020) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Debt (Qtr)
1 Eli Lilly 1,131.80 Bn 1,100.39 Bn 19.71 Bn 54.91 Bn
2 Johnson & Johnson 614.01 Bn 532.53 Bn 17.26 Bn 49.04 Bn
3 AbbVie 503.59 Bn 476.70 Bn 12.70 Bn 70.82 Bn
4 Merck 367.41 Bn 321.79 Bn 12.21 Bn 53.91 Bn
5 Novartis Ag 297.81 Bn 261.80 Bn 11.24 Bn 9.59 Bn
6 Astrazeneca 261.50 Bn 235.19 Bn 12.86 Bn 32.35 Bn
7 Amgen 236.24 Bn 191.64 Bn 7.24 Bn 57.30 Bn
8 Gilead Sciences 191.15 Bn 165.35 Bn 6.22 Bn 26.25 Bn
9 Pfizer 170.16 Bn 116.81 Bn 10.94 Bn 63.19 Bn
10 Context Therapeutics 22.15 Mn -218.31 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2020 5.95 Mn
API Access

Context Therapeutics Total Debt API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=total-debt&ticker=CNTX&period=max&api_key=YOUR_API_KEY